# Obinl

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/obinl

- Industry: Biotechnology
- Headquarters: Wuhan, China
- Latest round: Angel (Jun 8, 2022)
- Investors on record: 1

## About

Based in Wuhan, China, and founded in 2019,  Obinl is a biotechnology company that focuses on the research and development of acoustic tweezers equipment. Xin Yang, the founder of the company, has nearly 20 years of R&D experience in the field of medical ultrasound, acoustic tweezer technology, and biomedical engineering. In May 2023, it raised pre-series A funding from Lingyi Capital. In December 2023, Obinl closed a pre-series A3 funding.

The company's main business is the research and development of acoustic tweezers equipment. Products include single-cell printers, micro-pipette systems, exosome enrichment instruments, etc. Its single-cell printer uses acoustic tweezers manipulation technology to achieve automated sorting of single cells, which can be widely used in antibody discovery, synthetic biology, single-cell omics and other scenarios.

The company generates revenue by providing acoustic tweezers equipment and related products.

The company will use the pre-series A3 funding to develop new products, expand capacity and markets.

## Funding rounds

- Angel, Jun 8, 2022 — East Lake Ventures

## Investors

- East Lake Ventures (https://capitalatlas.ai/funds/east-lake-ventures) — Angel